期刊文献+

青年乳腺癌临床病理特征及分子分型分析 被引量:6

Clinico- pathologic characteristics and molecular phenotypes of breast cancer in young patients
下载PDF
导出
摘要 目的:探讨青年乳腺癌临床病理特征及分子分型情况。方法:收集陕西省肿瘤医院2012年1月至2015年6月经手术切除、病理证实的年龄≤35岁的青年乳腺浸润性导管癌病例64例,随机抽取同期年龄>35岁的中老年乳腺浸润性导管癌66例作为对照,回顾性分析其临床病理特征及分子分型情况。结果:青年乳腺癌与中老年乳腺癌在肿瘤大小、病理分期、淋巴结转移及Ki-67表达方面差异有统计学意义(P<0.05),二者分子分型的分布差异无统计学意义(P>0.05)。结论:青年乳腺癌肿瘤体积大,病理分期晚,Ki-67表达指数高,应重视其早期筛查与治疗,其高侵袭转移机制有待进一步研究。 Objective: To investigate the clinico- pathologic characteristics and molecular phenotypes of breast cancer in young patients. Methods: Data from 64 cases of infiltrating ductal carcinoma in young patients( age ≤35years) who underwent surgery between January 2012 and June 2015 were reviewed. 66 cases of infiltrating ductal carcinoma in middle- aged and elderly patients( age > 35 years) during the corresponding period were randomly selected as controls. The clinico- pathologic characteristics and molecular phenotypes were retrospectively analyzed. Results:The young patients of breast cancer significantly different from the middle- aged and elderly patients in terms of tumor size,pathologic stage,lymph node metastasis and the expression of Ki- 67( P < 0. 05). There were no significant differences of the molecular phenotypes between them( P > 0. 05). Conclusion: Young patients of breast cancer have larger size,more lated pathologic stage and higher expression of Ki- 67 compared with the middle- aged and elderly. Early screening and prompt treatment are necessary for young patients of breast cancer. The mechanisms of the strong invasion and metastasis still need further study.
出处 《现代肿瘤医学》 CAS 2016年第5期740-742,共3页 Journal of Modern Oncology
关键词 青年乳腺癌 临床病理特征 分子分型 young breast cancer clinico-pathologic characteristics molecular phenotype
  • 相关文献

参考文献15

  • 1W. C. Wood,A. S. Coates,R. D. Gelber,B. Thrlimann,H.-J. Senn.Strategies for subtypesdealing with the diversity of breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011. Annals of Oncology . 2011
  • 2S. El-Zaemey,N. Nagi,L. Fritschi,J. Heyworth.??Breast cancer among Yemeni women using the National Oncology Centre Registry 2004–2010(J)Cancer Epidemiology . 2012 (3)
  • 3Naoki Niikura,Shinobu Masuda,Nobue Kumaki,Tang Xiaoyan,Mizuho Terada,Mayako Terao,Takayuki Iwamoto,Risa Oshitanai,Toru Morioka,Banri Tuda,Takuho Okamura,Yuki Saito,Yasuhiro Suzuki,Yutaka Tokuda.??Prognostic significance of the Ki67 scoring categories in breast cancer subgroups(J)Clinical Breast Cancer . 2013
  • 4Akemi Kataoka,Eriko Tokunaga,Norikazu Masuda,Tadahiko Shien,Kimiko Kawabata,Mika Miyashita.??Clinicopathological features of young patients (<35 years of age) with breast cancer in a Japanese Breast Cancer Society supported study(J)Breast Cancer . 2014 (6)
  • 5Lindsey A. Torre,Freddie Bray,Rebecca L. Siegel,Jacques Ferlay,Joannie Lortet‐Tieulent,Ahmedin Jemal.Global cancer statistics, 2012[J]. CA: A Cancer Journal for Clinicians . 2015 (2)
  • 6Gul Alco,Atilla Bozdogan,Derya Selamoglu,Kezban Pilanc?,S?tk? Tuzlal?,Cetin Ordu,Sefik Igdem,Sait Okkan,Maktav Dincer,Gokhan Demir,Vahit Ozmen.??Clinical and histopathological factors associated with Ki-67 expressionin breast cancer patients(J)Oncology Letters . 2015 (3)
  • 7Haitao Li,Xinghua Han,Yingxin Liu,Guodong Liu,Guomin Dong.??Ki67 as a predictor of poor prognosis in patients with triple?negativebreast cancer(J)Oncology Letters . 2015 (1)
  • 8Cynthia Villarreal-Garza,Bertha Alejandra Martinez-Cannon,Alejandra Platas,Pier Ramos-Elias.??Specialized programs to support young women with breast cancer(J)Current Opinion in Supportive and Palliative Care . 2015 (3)
  • 9陈楠,党诚学,王晓燕,宋张骏,陆建荣,韩丕华,赵斌.Ki67在三阴性乳腺癌中的表达及与C-erbB-2的关系[J].现代肿瘤医学,2012,20(8):1631-1633. 被引量:8
  • 10Tang LC,Jin X,Yang HY,et al.Luminal B subtype:A key factor for the worse prognosis of young breast cancer patients in China. BMC Cancer . 2015

二级参考文献15

  • 1李宝江,朱志华,王军业,侯景辉,赵进明,张蓬原,姚广裕,王曦,龙浩,杨名添,戎铁.Ki67、P53、VEGF和C-erbB-2在乳腺癌组织中表达的相关性研究及其临床意义[J].癌症,2004,23(10):1176-1179. 被引量:126
  • 2Nielsen TO,Hsu FD,Jensen K,et al. Advantage and the incidence of the basalcarcinoma[ J]. Clin Cancer Res,2006,10(2) :5367 - 5374.
  • 3Dent R, Trudeau M, Pritchard KJ, et al. Triple negative breast cancer: clinical features and patterns of recurrence [ J ]. Clin Cancer Res,2007,13 ( 5 ) :4429 - 4434.
  • 4MarcTiscbkowitz, Jean -Sebastien Brunet, LouisR Begin. Use of immunohistochemical markers can refine prognosis in triple negative breast cancer[ J]. BMC Cancer,2007,7: 134.
  • 5Tan PH,Bay BH, Yip G, et al. Immunohistochemical detection of Ki67 in breast cancer correlates with transcriptional regulation of genes related to apoptosis and cell death [ J]. Mod Pathol,2005,18(3) : 374 -381.
  • 6Retsky M,Baum M,Demicheli R,et al. Prognostic value of k67 expression after short - term presurgical endocrine therapy for primary breast cancer [ J ]. J Natl Cancer Inst,2007,99 ( 13 ) : 1053 - 1054.
  • 7Xu T, Zhu Y, Xiong Y, et al. Ki67 suppresses tumorigenicity and regulates G1/S transition of human hepatocellular carcinoma cells [ J]. Hepatology, 2009,50( 1 ) : 113 - 121.
  • 8Bauer KR, Brown M,Cress RD. Descriptive analysis of estrogen re- ceptor (ER) - negative, progesterone receptor (PR) - negative, and HER2 - negative invasive breast cancer, the so - called triple - negative phenotype : a population - based study from the California Cancer Registry[ J]. Cancer,2007,109 : 1721 - 1728.
  • 9Volpi A, Nannl O, Depaola F. The expression of HER -2 and ki67 prognosticmarkers in patientswith node - negative breast cancer[ J]. Natl Cancer Inst,2003,21 (14) :2708 - 2712,.
  • 10Bhatavdekar JM, Patel DD, Shah NG, et al. Prognostic significance of immunohisto - chemically localized biomarkers in ki67 and cancer: a multivariate analysis [ J ]. Ann Surg Oncol,2008, 7:305 -311.

共引文献59

同被引文献55

引证文献6

二级引证文献32

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部